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Report
Cardiovascular autonomic dysfunction in
primary Sjo¨gren’s syndrome
La´szlo´ Kova´cs, Do´ra Paprika1, Ro´bert Taka´cs2, Attila Kardos3,
Tama´s T. Va´rkonyi2, Csaba Lengyel2, Attila Kova´cs, La´szlo´ Rudas1 and
Gyula Pokorny
Objective. To assess the occurrence and clinical signiﬁcance of a cardiovascular autonomic nervous system dysfunction in
primary Sjo¨gren’s syndrome (pSS).
Methods. Fifty-one pSS patients participated in this case-control study. Heart rate and blood pressure variability
measurements, spontaneous baroreﬂex sensitivity examinations and cardiovascular reﬂex tests were performed.
Results. The results of the heart rate and blood pressure variability measurements and also the baroreﬂex sensitivity parameters
of the pSS patients peaked in the lowest percentile ranges of a database on 559 healthy control subjects (P<0.05). In three of
the ﬁve cardiovascular reﬂex tests, the frequencies of abnormal results were signiﬁcantly higher among the patients than among
the controls (P<0.05), and the median autonomic neuropathy score was also elevated (3 vs 0 in the controls; P<0.0001).
Conclusion. Signs of an autonomic nervous system dysfunction involving the cardiovascular system can be discerned in the
majority of pSS patients.
KEY WORDS: Antireceptor antibody, Autonomic dysfunction, Baroreﬂex sensitivity, Blood pressure variability,
Cardiovascular reﬂex test, Heart rate variability, Primary Sjo¨gren’s syndrome.
There is increasing evidence that decreased stimulation by the
autonomic nervous system of the salivary and lacrimal glands
plays an important role in the elicitation of the exocrine
dysfunction in primary Sjo¨gren’s syndrome (pSS) [1]. Antibodies
to the muscarinic acetylcholine receptor subtype 3 (m3AchR)
have been demonstrated in pSS [2–4]. Cardiovascular autonomic
neuropathy has been investigated in pSS by various study groups
[5–11]; however, possibly as a consequence of the differences in the
methods applied, the results are not consistent. Therefore, with
regard to the emerging importance of anti-mAchR autoantibodies
in pSS, and the clinical signiﬁcance of an autonomic nervous
system dysfunction, we attempted to clarify the occurrence and
severity of cardiovascular autonomic neuropathy by using both
the standard cardiovascular reﬂex tests and the more sensitive and
up-to-date heart rate variability (HRV) examinations.
Patients and methods
Study patients
A questionnaire relating to symptoms that may potentially be
caused by an autonomic dysfunction was completed by 51 pSS
patients [48 women, average age 53 yr (range 31–71 yr)]. All of
them fulﬁlled the American–European classiﬁcation criteria for
pSS [12]. Patients older than 75 yr or those with diabetes mellitus
or any other disease that may cause an autonomic neuropathy
were not included in this study, the examined patient population
was otherwise unselected.
Examination of heart rate and blood pressure variability
Heart rate (HR) and blood pressure (BP) were recorded
continuously for a period of 10min with a Marquette bedside
ECG monitor and with a Finapres 2300 non-invasive beat-to-beat
BP monitor (Ohmeda, St Louis, MO), respectively.
The following standard HRV and blood pressure variability
(BPV) indices were calculated. (i) The time domain analysis yields
descriptive statistical data on the variability of the cycle length
(RR-interval) and BP values registered during the 10-min
examination period: minimum, maximum and mean RR-interval;
SDRR (standard deviation of the mean RR-interval); RMSSD
(the square root of the average of the squared differences between
each consecutive RR-interval); pNN50 (the percentage of intervals
that differed from the adjacent interval by >50ms); and the
minimum, maximum and mean systolic BP (SBP) [13]. (ii)
Frequency domain analysis involves power spectral analysis of the
effects modulating the oscillations in the RR-intervals and SBP.
Parameters indicating the impacts on SBP in the low-frequency
(LF) or high-frequency (HF) band (LF-SBP, HF-SBP) and of
the RR-interval values in the LF band (LF-RRI) were calculated.
(iii) As the vagus nerve is the efferent pathway of the baroreﬂex
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circuit, the measurement of baroreﬂex sensitivity (BRS) provides
precise data on the parasympathetic innervation of the heart [14].
Spontaneous BRS can be assessed at rest during the simultaneous
registration of RR-interval and SBP values, as with an intact
baroreﬂex function, every spontaneous rise or fall in BP is
immediately followed by the appropriate change in the HR. The
slope of the function of coupled RR-interval and SBP changes was
considered as a measure of BRS.
We compared our results on pSS patients with our previous
results obtained by the systematic examination of a large healthy
population of 559 subjects [15]. Since the control group comprised
persons with a maximum age of 60 yr, of the original 51 pSS
patients only those aged 60 yr or below could be evaluated. As
three further patients who had either organic heart disease or
extrasystolia were also excluded from the HRV/BPV studies, 39
patients (37 women) remained eligible for these examinations.
For methodological reasons, the evaluation of BRS was feasible
in 30 patients.
Cardiovascular reﬂex tests
Five simple and fast tests were carried out following the standard
methods of Ewing et al. [16]: (i) HR changes in response to deep
breathing; (ii) HR changes in response to the Valsalva manoeuvre;
(iii) HR changes in response to standing up (30/15 ratio); (iv) SBP
changes in response to standing up; (v) diastolic BP changes in
response to a sustained handgrip. In every test, normal values were
scored 0, borderline values 1 and abnormal values 2. The sum of
the scores gave the total autonomic neuropathy score [16]. A score
of 0–1 was taken as normal, 2–3 as borderline and>3 as abnormal
[16]. Patients with organic cardiac disease or any arrhythmia, or
those who were treated with beta- or alpha-adrenergic receptor
blockers or vasodilating drugs were not eligible. After the
exclusion of these patients, the tests were performed on 39 patients
(37 women) and the results were compared with those on 39 age-
and sex-matched healthy controls.
Sensory nerve function assessment
The somatic sensory nerve function was assessed by examination
of the vibration perception threshold with a calibrated vibrameter.
Statistical methods
In the HRV, BPV and BRS examinations, to test whether the
numbers of patients in the various percentile ranges differ from the
expected distribution, the 2 test was used. Cardiovascular reﬂex
test results on the patients and the controls were compared via a
Mann–Whitney U-test or a 2 test. The relationships between the
results of the examinations and the various patient data were
analysed with Spearman’s rank correlation test or with a Mann–
Whitney U-test.
Results
Nine patients experienced palpitations, three reported complaints
consistent with orthostatic hypotension and one patient mentioned
episodes of presyncope.
For the purpose of comparison with the healthy controls, the 37
participating pSS patients were allocated into four subgroups
according to age and sex. For each of the test parameters, we
deﬁned the percentile values in the appropriate age and gender
subgroup of healthy controls for the results on every patient. The
mean RR-interval and SBP values were distributed relatively
evenly in the patients, similarly to their distribution in the healthy
population (P>0.05). In contrast, the SDRR, pNN50, RMSSD,
LF-RRI, HF-RRI and LF-SBP percentile values were clustered in
the lowest percentile range, i.e. the majority of the pSS patients
exhibited parameters that were below the 20th percentile for
the corresponding age- and sex-matched healthy population
(P<0.001 for all parameters). Similarly, we noted a signiﬁcant
difference from the normal distribution (P<0.05) with regard to
the BRS values. In summary, pSS patients have HR and BP values
similar to those in the healthy population, but the variability
in both the HR and the BP is restricted and BRS is decreased.
In Fig. 1, we present the distribution of selected, representative
parameters in the pSS patients and the healthy controls.
The results of the cardiovascular reﬂex tests are summarized in
Fig. 2. In every test, higher percentages of the pSS patients than of
the controls demonstrated an abnormal result, and this difference
was statistically signiﬁcant in two parasympathetic and one
sympathetic test (P<0.05). When the average values were
compared between the two groups, the pSS patients exhibited
signiﬁcantly lower median values in the tests of the HR response to
standing up (1.0 vs 1.12, P<0.001) and to deep breathing (14 vs
21 beats/min, P<0.05) and of the diastolic BP change in response
to a sustained handgrip (16 vs 25mm Hg; P<0.001), while in the
two remaining tests, the average values of the two groups were
not signiﬁcantly different. Sixteen patients gave abnormal and
17 borderline autonomic neuropathy scores [total: 33 (85%) vs
7 (18%) in the controls; P<0.0001]. The median autonomic
neuropathy score in the patient group was 3 (range 1–8), while that
in the control group was 0 (range 0–5; P<0.0001).
Similarly, as in the general population [15], the BRS values
displayed a signiﬁcant negative correlation with age (r¼ –0.44,
P¼ 0.012). None of the above test results correlated with the pSS
duration, the presence of any extraglandular manifestation or
immunoserological positivity, the sensory nerve function or the
stimulated saliva production. The nine patients who reported
palpitations had lower values (i.e. more abnormal) of all of the
HRV and BPV parameters than the patients without this
complaint; this difference was statistically signiﬁcant in the case
of RMSSD (P¼ 0.026) and was close to the border of statistical
signiﬁcance in the cases of pNN50 (P¼ 0.073) and down-BRS
(P¼ 0.076).
Discussion
In this trial, we investigated the prevalence, severity and clinical
correlates of cardiovascular autonomic dysfunction in pSS
patients. The methods applied are accepted methods for the
assessment of autonomic neuropathy; however, as anti-AchR
autoantibodies are a special feature in pSS, and these antibodies
may also inﬂuence the innervation mechanism, we prefer use of the
term autonomic dysfunction to autonomic neuropathy.
The examination of HRV and BPV revealed that, while having a
normal HR and BP in general, a great majority of the pSS patients
have a restricted variability of both HR and BP. HRV and BPV
reﬂect the continuous adaptation of the circulation to the changing
conditions, and are mediated predominantly by the autonomic
nervous system. In view of the physiological correlates of the
particular parameters [13], our results conclusively indicate that
signs of both a sympathetic and a parasympathetic cardiovascular
autonomic dysfunction can be observed in a great proportion of
pSS patients.
The cardiovascular reﬂex tests also revealed marked differences
as compared with the healthy controls, but these data are far less
consistent. The ratio of patients with an abnormal result was
statistically signiﬁcantly higher than in the controls in only two of
the three parasympathetic tests and in one of the two sympathetic
tests. The median global score was 3, which is a borderline value,
being much lower than that for diabetic patients, for whom
average scores of 6 or even higher are the typical published values
[17, 18].
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Previous studies on this topic found signs of a parasympathetic
and a sympathetic dysfunction in rather variable proportions of
pSS patients (between 24 and 100% in the various tests). Although
the methods of these investigations ranged from simple autonomic
reﬂex tests and reﬂex test panels to spectral HRV and BPV
analyses, the control selection procedures were very similar. Age-
and sex-matched healthy volunteers were recruited, and the
control/patient ratio seldom exceeded 1:1. It seems that autonomic
reﬂex tests perform best in diabetic populations [16]. It is well
documented that gross abnormalities indicating severe neuropathy
are associated with an adverse outcome [19]. Therefore, these tests
are well suited for the mass screening and risk stratiﬁcation of
diabetics in routine clinical practice. More subtle abnormalities of
the cardiovascular autonomic regulation might be difﬁcult to
assess by reﬂex test methods.
In contrast with the reﬂex test studies, conclusive results were
obtained from the HRV/BPV and BRS analyses. Some of the
variables assessed in our present study, such as the spontaneous
BRS, have been shown to vary tremendously in the healthy
population [15, 20]. Comparisons with single age- and sex-matched
control subjects may therefore be subject to chance inﬂuences.
Accordingly, we related the variables of the pSS subjects to a large
database on age- and sex-matched healthy volunteers.
In summary, we conclude that a cardiovascular autonomic
dysfunction is common, but usually relatively mild in pSS, and
only the sensitive HRV examination and the application of a large
control population are suitable for a consistent demonstration of
its presence. In view of its high occurrence, one can speculate that
it has some pathogenic role in this disease. It was earlier reported
that a 25 amino acid epitope of the human m2AchR, which is the
functioning receptor subtype in the heart [21], did not react
with the serum of any of the examined pSS patients [4]. However,
these ﬁndings do not preclude that anti-m2AchR antibodies with
different epitope speciﬁcities may operate. An autonomic
neuropathy may be a further potential mechanism. Due to its
potential pathophysiological signiﬁcance, we consider it worth-
while to further characterize the potential immunological
mechanisms which lead to autonomic nervous system abnormal-
ities in pSS.
On the other hand, the clinical consequences of the cardiovas-
cular autonomic dysfunction are generally mild. Our pSS patients
rarely experienced symptoms potentially attributable to it, and
FIG. 1. Representative diagrams of four parameters recorded during the HRV and BPV measurements. The results are represented as
percentile values of those for a group of age- and sex-matched healthy individuals. As an illustration, the percentile distribution of the
healthy subjects is also presented. MeanRRI, mean RR-interval. There was no signiﬁcant difference between the patients and the
controls (P>0.05), i.e. the average resting heart rate was similar in the two groups. RMSSD, a time domain analysis parameter
relating mainly to a parasympathetic nervous system dysfunction. LF-SBP, a frequency domain analysis parameter relating mainly to
a sympathetic nervous system dysfunction. BRS, baroreﬂex sensitivity. For the latter three parameters, the distribution of the patients
in the various percentile ranges is signiﬁcantly different from that of the controls (P<0.001). For a more detailed explanation of the
parameters, see Patients and methods.
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signiﬁcant cardiac symptomatology has not been reported in
studies on large cohorts of pSS patients [22]. Nevertheless, upon
direct questioning, nine of the pSS patients (18%) reported
episodes of palpitations. Notably, in these patients the autonomic
dysfunction was more pronounced than in the pSS patients
without this symptom when examined with the HRV/BPV
examinations, while the reﬂex tests failed to identify these patients.
We conclude that it is not warranted to routinely test every pSS
patient, but in occasional patients with complaints suggestive of an
autonomic dysfunction, short-term HRV/BPV examinations are
FIG. 2. The distributions of the results of the cardiovascular reﬂex tests in the pSS patients and the controls. (a) Tests relating mainly
to the parasympathetic function: heart rate changes in response to deep breathing (HRV), to the Valsalva manoeuvre, and to standing
up (30/15). (b) Tests relating mainly to the sympathetic function: SBP changes in response to standing up (orthostatic challenge: ortho)
and diastolic BP changes in response to a sustained handgrip (handgrip). The total autonomic neuropathy score (AN score) results are
also presented here. Cont, control; NS, non-signiﬁcant difference.
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useful in the veriﬁcation of an underlying autonomic nervous
system abnormality, while the cardiovascular reﬂex tests are less
valuable in this respect because of their lower sensitivity.
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1. Cardiovascular autonomic dysfunction
was revealed in the majority of pSS
patients.
2. It is usually clinically mild.
3. HRV measurements are superior to
reﬂex tests in its detection.
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